Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
1060-101 Angiographically apparent thrombus after fibrinolytic administration is associated with impaired epicardial flow and myocardial perfusion in ST elevation myocardial infarction patients with open arteriesJournal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A262-A262 [Peer Reviewed Journal]2004 ;Copyright Elsevier Limited Mar 3, 2004 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/S0735-1097(04)91114-XFull text available |
2 |
Material Type: Article
|
![]() |
1061-88 Causes of death in patients with ST elevation myocardial infarction treated with fibrinolysisJournal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A263-A263 [Peer Reviewed Journal]2004 ;Copyright Elsevier Limited Mar 3, 2004 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/S0735-1097(04)91119-9Full text available |
3 |
Material Type: Article
|
![]() |
1098-78 Low hemoglobin predicts worse clinical outcomes in acute coronary syndromesJournal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A278-A278 [Peer Reviewed Journal]2004 ;Copyright Elsevier Limited Mar 3, 2004 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/S0735-1097(04)91180-1Full text available |
4 |
Material Type: Article
|
![]() |
2019 REVIEWERS FOR ENDOCRINE PRACTICEEndocrine practice, 2020-01, Vol.26 (1), p.142-155 [Peer Reviewed Journal]Copyright Allen Press Publishing Services Jan 2020 ;ISSN: 1530-891X ;EISSN: 1934-2403 ;DOI: 10.4158/1934-2403-26.1.142 ;PMID: 32022601Full text available |
5 |
Material Type: Article
|
![]() |
883-2 The association of race with angiographic and clinical outcomes following fibrinolytic administrationJournal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A305-A305 [Peer Reviewed Journal]2004 ;Copyright Elsevier Limited Mar 3, 2004 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/S0735-1097(04)91289-2Full text available |
6 |
Material Type: Article
|
![]() |
Abciximab facilitates the rate and extent of thrombolysis: Results of the thrombolysis in myocardial infarction (TIMI) 14 trialCirculation (New York, N.Y.), 1999-06, Vol.99 (21), p.2720-2732 [Peer Reviewed Journal]1999 INIST-CNRS ;Copyright American Heart Association, Inc. Jun 1, 1999 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/01.CIR.99.21.2720 ;CODEN: CIRCAZFull text available |
7 |
Material Type: Article
|
![]() |
Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction : Observations from the TIMI 14 trialCirculation (New York, N.Y.), 2000-01, Vol.101 (3), p.239-243 [Peer Reviewed Journal]2000 INIST-CNRS ;Copyright American Heart Association, Inc. Jan 25, 2000 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/01.CIR.101.3.239 ;PMID: 10645918 ;CODEN: CIRCAZFull text available |
8 |
Material Type: Article
|
![]() |
Abstract 11043: Clinical Safety Outcomes in Relation to Lipoprotein(a) Concentration: Insights from the FOURIER TrialCirculation (New York, N.Y.), 2021-11, Vol.144 (Suppl_1) [Peer Reviewed Journal]ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/circ.144.suppl_1.11043Full text available |
9 |
Material Type: Article
|
![]() |
Abstract 11524: Ezetimibe Consistently Reduces LDL-C with Little Interindividual Variability in 14,970 Patients Post-ACSCirculation (New York, N.Y.), 2021-11, Vol.144 (Suppl_1) [Peer Reviewed Journal]ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/circ.144.suppl_1.11524Full text available |
10 |
Material Type: Article
|
![]() |
Abstract 11748: Edoxaban versus Warfarin in Patients at Increased Risk of Falling - A Subgroup Analysis of the ENGAGE AF-TIMI 48 TrialCirculation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A11748-A117482015 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539Full text available |
11 |
Material Type: Article
|
![]() |
Abstract 11753: Outcomes in Women vs. Men After Non-ST-Elevation Acute Coronary Syndromes: Insights From the TIMI TrialsCirculation (New York, N.Y.), 2018-11, Vol.138 (Suppl_1 Suppl 1), p.A11753-A117532018 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539Full text available |
12 |
Material Type: Article
|
![]() |
Abstract 12195: Relationship Between Transcatheter Aortic Valve Replacement Wait Time and Mortality in Patients With Symptomatic Severe Aortic StenosisCirculation (New York, N.Y.), 2018-11, Vol.138 (Suppl_1 Suppl 1), p.A12195-A121952018 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539Full text available |
13 |
Material Type: Article
|
![]() |
Abstract 12361: Efficacy and Safety of NOACs vs. Warfarin Across the Continuous Range of Body Mass Index and Body Weight: Insights From COMBINE-AFCirculation (New York, N.Y.), 2022-11, Vol.146 (Suppl_1) [Peer Reviewed Journal]ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/circ.146.suppl_1.12361Full text available |
14 |
Material Type: Article
|
![]() |
Abstract 12680: Efficacy and Safety of Edoxaban Compared With Warfarin in Patients With Atrial Fibrillation and Heart Failure: Insights From Engage-AF TIMI 48Circulation (New York, N.Y.), 2014-11, Vol.130 (suppl_2) [Peer Reviewed Journal]ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/circ.130.suppl_2.12680Full text available |
15 |
Material Type: Article
|
![]() |
Abstract 13035: Impact of Ezetimibe on Hospitalization-Related Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT TrialCirculation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A13035-A130352015 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539Full text available |
16 |
Material Type: Article
|
![]() |
Abstract 13200: Relationship Between Baseline Low-Density Lipoprotein Cholesterol and Percent Low-Density Lipoprotein Cholesterol Reduction With Evolocumab in the FOURIER (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Patients With Elevated Risk) TrialCirculation (New York, N.Y.), 2020-11, Vol.142 (Suppl_3 Suppl 3), p.A13200-A13200 [Peer Reviewed Journal]2020 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/circ.142.suppl_3.13200Full text available |
17 |
Material Type: Article
|
![]() |
Abstract 13702: A Novel Genetic Risk Score Predicts Ischemic Stroke in Patients With Cardiometabolic DiseaseCirculation (New York, N.Y.), 2020-11, Vol.142 (Suppl_3 Suppl 3), p.A13702-A13702 [Peer Reviewed Journal]2020 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/circ.142.suppl_3.13702Full text available |
18 |
Material Type: Article
|
![]() |
Abstract 13833: Impact of Lowering LDL-C With Evolocumab on Everyday Cognition in Participants From the FOURIER TrialCirculation (New York, N.Y.), 2019-11, Vol.140 (Suppl_1 Suppl 1), p.A13833-A138332019 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/circ.140.suppl_1.13833Full text available |
19 |
Material Type: Article
|
![]() |
Abstract 13871: Evolocumab and Cardiovascular Outcomes in Patients With Recent Myocardial Infarction: Analysis From FOURIERCirculation (New York, N.Y.), 2019-11, Vol.140 (Suppl_1 Suppl 1), p.A13871-A138712019 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/circ.140.suppl_1.13871Full text available |
20 |
Material Type: Article
|
![]() |
Abstract 14083: Prognostic Significance of Left Ventricular Systolic Dysfunction at the Time of NSTEMI in Patients With No Prior History of Heart FailureCirculation (New York, N.Y.), 2019-11, Vol.140 (Suppl_1 Suppl 1), p.A14083-A140832019 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/circ.140.suppl_1.14083Full text available |